Understanding Allergic Rhinitis Symptoms
Understanding Allergic Rhinitis Symptoms
The diagnosis of allergic rhinitis often involves a total and differential white blood cell count, revealing peripheral eosinophilia. A nasal smear may show a large number of eosinophils, and skin tests are used to identify specific allergens causing the condition .
During mast cell degranulation in allergic rhinitis, several chemical mediators are released, including histamines and leukotrienes. These mediators lead to vasodilation, mucosal edema, infiltration with eosinophils, and excessive secretion from nasal glands. The resulting symptoms include nasal congestion, itching, and increased nasal discharge .
Immunotherapy, also known as hyposensitization, is considered in treating allergic rhinitis when drug treatment fails to control symptoms or leads to intolerable side effects. It works by gradually desensitizing the immune system to the offending allergens, reducing or eliminating the allergic response over time .
Sympathomimetic drugs alleviate allergic rhinitis symptoms by mimicking the effects of the sympathetic nervous system. These alpha-adrenergic drugs constrict blood vessels, reducing nasal congestion and edema. They can be administered orally or topically and are commonly combined with antihistamines to enhance effectiveness .
Antihistaminics, used in treating allergic rhinitis, generally control rhinorrhea, sneezing, and nasal itching but have drowsiness as a common side effect. This can affect patient compliance as it may interfere with daily activities, making patients reluctant to consistently take their medication .
Genetic predisposition plays a significant role in the pathogenesis of allergic rhinitis by influencing the production of specific IgE antibodies in response to inhalant allergens. Individuals with a genetic tendency are more likely to produce these antibodies, which then fix to mast cells and basophils, triggering allergic responses upon allergen exposure .
Allergic rhinitis is an IgE-mediated immunologic response where inhaled allergens trigger the production of specific IgE antibodies in genetically predisposed individuals. These antibodies attach to blood basophils or tissue mast cells. Upon re-exposure to the allergen, it binds to the IgE antibody, leading to mast cell degranulation. This releases chemical mediators that cause vasodilation, mucosal edema, eosinophil infiltration, excessive nasal gland secretion, and possible smooth muscle contraction .
Treatment strategies for allergic rhinitis can be categorized into three main areas: 1) avoidance of allergens, which is effective when the antigen is singular; 2) drug treatment, including antihistaminics to control symptoms, sympathomimetic drugs to reduce congestion, and corticosteroids for effective symptom control; 3) immunotherapy, which is used when drugs are ineffective or have intolerable side effects .
Eosinophils play a crucial role in allergic rhinitis by contributing to the inflammation of nasal tissues. They are responsible for the tissue infiltration observed in nasal smears and peripheral blood tests, leading to symptoms such as nasal congestion, obstruction, and discharge. The presence of eosinophils correlates with allergic inflammation severity .
Seasonal allergic rhinitis symptoms, which appear during specific seasons due to pollen presence, include sneezing (10-20 sneezes at a time), nasal obstruction, watery nasal discharge, and nasal itching. Perennial allergic rhinitis symptoms, which persist year-round, include a persistently stuffy nose, loss of smell because of mucosal edema, and chronic cough .